Avivagen Inc is a Canada-based life sciences company. It develops products for livestock feeds to replace antibiotics for growth promotion and to help prevent disease by supporting the animal’s own health defenses. Its segments include products based on fully-oxidized beta-carotene (OxC-beta) technology and chemistry product sales. Its OxC-beta technology is in trials as a non-antibiotic feed additive. Its products include OxC-beta Livestock, Vivamune Health Chews and Oximunol Chewable Tablets. Its Vivamune Health Chews are supplements that are suitable for pets in all life stages and can be given to dogs and cats as young as over five weeks of age. The Oximunol Chewable Tablets are available in bottles through veterinarians across the United States. The OxC-beta Livestock is available for sale in Taiwan, Thailand and the Philippines. Its customers include government agencies, global health organizations, livestock producers and end market food companies.